Bristol-Myers Squibb Company (BMY) Fundamentals

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
SHARE INFORMATION
Market Cap$ 159,845,201,128
Shares Outstanding2,135,255,158
Float2,133,801,214
Percent Float99.93%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 2.01
Latest Fiscal Revenue$ 46,385,000,000
Latest Fiscal EPS$ 3.12
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 10.59
Dividend (5 Years)$ 11.43
Ex Dividend Date2022-06-30
Dividend Rate$ 2.16
Dividend Yield2.89%
Payment CashCash
HOLDERS
Institutions4,030
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months160,443,585
Institutional Holdings Percent145.3%
Institutional Sold Previous 3 Months198,522,390
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months27,134
Insider Holdings Percent0.3
Insider Sold Previous 3 Months114,658
Insider Shares Owned6,397,989
TRADING INFO
52 Week High$ 80.59
52 Week Low$ 53.22
52 Week High Change$ 14.61
21 Day Moving Average$ 73.6852
21 Day Extended Moving Average$ 74.0087
50 Day Moving Average$ 74.7149
50 Day Extended Moving Average$ 74.5152
200 Day Moving Average$ 68.1585
200 Day Extended Moving Average$ 70.8996
10 Day Average Volume8,992,557
20 Day Average Volume9,077,866
30 Day Average Volume9,415,259
50 Day Average Volume11,315,012
Alpha0.004892
Beta0.4026
Standard Deviation0.063030
R20.102088
7 Day Price Change$ 1.87
7 Day Percent Change2.56%
21 Day Price Change$ 2.04
21 Day Percent Change2.8%
30 Day Price Change$ -0.52
30 Day Percent Change-0.69%
Month to Date Price Change$ 1.08
Month to Date Percent Change1.46%
Quarter to Date Price Change$ -2.14
Quarter to Date Percent Change-2.78%
180 Day Price Change$ 9.29
180 Day Percent Change14.17%
200 Day Price Change$ 12.22
200 Day Percent Change19.51%
Year to Date Price Change$ 13.93
Year to Date Percent Change22.86%

Bristol-Myers Squibb Company (BMY) Key Ratios

PROFITABILITY
EBIT Margin19.0%
EBITDA Margin41.2%
Pre-Tax Profit Margin13.9%
Profit Margin Count14.01%
Gross Margin78.8%
Profit Margin TOT14.01%
INCOME STATEMENTS
Revenue$ 47,144,000,000
Revenue Per Share$ 22.0789
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-6.10
Total Debt To Equity1.30
Int Coverage6.90
Current Ratio1.40
Leverage Ratio3.10
Quick Ratio1.20
Long Term Debt To Capital0.54
VALUATION MEASURES
PE Ratio24.90
Enterprise Value$ 189,834,726,643
Price to Sales3.3906
Price to Free Cash18.60
PE High Last 5 Years116.80
Price To Book4.90
Price To Cash Flow10.70
PE Low Last 5 Years-13.30
Price to Tangible Book-6.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.20
Invoice Turnover4.50
Assets Turnover0.40
Return Assets6.67
Return on Equity20.32
Return on Capital9.74

Bristol-Myers Squibb Company (BMY) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOGiovanni Caforio
Emplyoees32200
Last AuditUQ
CIK0000014272
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address430 E. 29th Street
14th Floor
New York, NY 10016
Websitehttps://www.bms.com
Facsimile-
Telephone+1 212 546-4000
Emailtimothy.power@bms.com


Your Recent History
NYSE
BMY
Bristol My..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.